Cipher Pharmaceuticals Inc (CPH.TO) has had a mixed performance recently, with a slight uptick in today’s trading amidst a broader context of declining weekly performance.
This week, Cipher Pharmaceuticals Inc's stock closed at C$16.42, reflecting a modest increase of 0.06% for the day. However, the stock has experienced a decline of 4.26% over the past week, despite a year-to-date gain of 10.07%. Investors may want to understand the factors influencing this stock's recent movements.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeAdvertisement
Market cap
$356.72M
P/E
8.5x
52W high
$20.56
52W low
$12.48
1W change
-21.18%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 47.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+47.5% Upside
Current Price
C$13.99
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.8%
Annualized
90-Day Vol
51.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.18 | C$10.22 – C$17.01 |
| 60 trading days | C$12.42 | C$8.66 – C$17.81 |
| 90 trading days | C$11.70 | C$7.53 – C$18.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Cipher Pharmaceuticals continues to present a compelling investment opportunity for those in the healthcare sector, given its strong financial performance and positive analyst outlook. However, the recent decline in stock price may warrant caution for short-term investors.
Cipher Pharmaceuticals' stock has a P/E ratio of 9.70 and a profit margin of 60.6%.
With a market cap of approximately C$416 million and an EPS of 1.69, Cipher Pharmaceuticals demonstrates robust profitability and returns, making it an attractive consideration for long-term investors in the healthcare sector.
Bull case
The company has reported impressive financial results in recent quarters, showing significant year-over-year increases in revenue and net income. This positive trend could attract more investors and drive stock prices higher.
Bear case
Despite strong fundamentals, the recent dip in stock price may reflect broader market trends or investor sentiment, indicating potential volatility ahead for short-term investors.
Recent Price Action
Cipher Pharmaceuticals Inc (CPH.TO) has shown a slight increase of 0.06% in today's trading, closing at C$16.42. However, over the past week, the stock has seen a decline of 4.26%. The year-to-date performance remains positive, with a gain of 10.07%. The current trading volume is 4,155 shares, which is 1.28 times the 20-day average volume of 12,872 shares.
Company News and Web Headlines
Advertisement
No major company news has been reported this week. However, recent headlines indicate that Cipher Pharmaceuticals has been performing well financially. For instance, the company reported record revenue and earnings for the year 2025, with a 51% increase in revenue and a 137% rise in net income compared to the previous year. These results may have contributed to the stock's overall performance this year.
Technical Picture
Examining Cipher Pharmaceuticals' technical indicators, the stock is currently trading below its 50-day moving average of C$16.84, which is a decline of 2.5%. However, it is above its 200-day moving average of C$15.84, representing a positive divergence of 3.7%. The stock's 52-week range has been between C$11.98 and C$20.56, indicating that it is currently at 52% of its range.
Insider Activity
No recent insider activity has been reported for Cipher Pharmaceuticals, which may suggest stability in management and ownership structure.
Price Action Summary
As of the last close, Cipher Pharmaceuticals Inc (CPH.TO) is priced at C$16.42, reflecting a slight increase of 0.06% for the day.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
